Cargando…
Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes?
There is a lack of studies assessing if race impacts the efficacy of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) inhibitor (“statin”) therapy on renal transplantation (RTx) outcomes. We examined the association between statin therapy and RTx outcomes, while concurrently quantifying the effect...
Autores principales: | Ozieh, Mukoso N., Taber, David J., Egede, Leonard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008522/ https://www.ncbi.nlm.nih.gov/pubmed/26656377 http://dx.doi.org/10.1097/MD.0000000000002283 |
Ejemplares similares
-
A Lifestyle Intervention to Delay Early Chronic Kidney Disease in African Americans With Diabetic Kidney Disease: Pre-Post Pilot Study
por: Ozieh, Mukoso N, et al.
Publicado: (2022) -
Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis
por: Cho, AJin, et al.
Publicado: (2020) -
Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study
por: Chen, Keliang, et al.
Publicado: (2017) -
Creating a 13-year National Longitudinal Cohort of veterans with chronic kidney disease
por: Ozieh, Mukoso N., et al.
Publicado: (2019) -
Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
por: Villa, Luigi, et al.
Publicado: (2021)